psychologists and psychiatric drugs

classic Classic list List threaded Threaded
11 messages Options
Reply | Threaded
Open this post in threaded view
|

psychologists and psychiatric drugs

Paul Coffman
I was wondering if anyone would share if they've seen psychologists about
their eSens issues and if they were any help, and if anyone has tried
antidepressants like lexapro and other drugs and what effect they had on
their senstivities. Personally, I've seen a hypnotherapist with basically
no success and tried lexapro but couldn't tolerate it long enough to
experience any of the 'good' effects.

--
Paul Coffman


[Non-text portions of this message have been removed]

Reply | Threaded
Open this post in threaded view
|

Re: psychologists and psychiatric drugs

furnitureguru1
I strongly recommend that you stay as far as possible (Preferably 35,000 miles) away from Psychologists and Psychiatrists.

They have a track record of hurting rather than helping.

Of course, stay away from all mind altering drugs.

I am doing a mercury/aluminum detox and feel much better since then. I also have more energy and am mentally sharper. Emotionally I am also healthier.

I also use Bio Pro products on all of my phones and have been retested (muscle testing) on my phones and environment and am finally getting more resistant to EMF!!!

Thank everyone for their input.

Paul


----- Original Message -----
From: Paul Coffman
To: [hidden email]
Sent: Thursday, May 24, 2007 11:57 AM
Subject: [eSens] psychologists and psychiatric drugs


I was wondering if anyone would share if they've seen psychologists about
their eSens issues and if they were any help, and if anyone has tried
antidepressants like lexapro and other drugs and what effect they had on
their senstivities. Personally, I've seen a hypnotherapist with basically
no success and tried lexapro but couldn't tolerate it long enough to
experience any of the 'good' effects.

--
Paul Coffman

[Non-text portions of this message have been removed]



   

[Non-text portions of this message have been removed]

Reply | Threaded
Open this post in threaded view
|

Re: psychologists and psychiatric drugs

Marc Martin
Administrator
In reply to this post by Paul Coffman
> I was wondering if anyone would share if they've seen psychologists about
> their eSens issues and if they were any help, and if anyone has tried
> antidepressants like lexapro and other drugs and what effect they had on
> their senstivities.

Early on in my ES (7 years ago), I found that taking antibiotics
eliminated my ES, but these were causing other problems and
certainly were not something that I wanted to be taking
forever. And they were only a temporary solution, as soon
as I stopped taking them, my ES came back.

The fact that antibiotics helped at all is rather interesting
though, and leads me to wonder what the mechanism of action was.
I can only think of two possibilities:

* my ES is caused by some sort of chronic infection.
* my ES is caused by excessive mobilization of toxins,
and the antibiotics interferred with this.

But I agree that going to a psychologist is probably useless.
This is a physical condition, not a mental one.

Marc

Reply | Threaded
Open this post in threaded view
|

Re: psychologists and psychiatric drugs

Marc Martin
Administrator
In reply to this post by furnitureguru1
> I also use Bio Pro products on all of my phones and have been retested
> (muscle testing) on my phones and environment and am finally getting more
> resistant to EMF!!!

Can you actually tell the difference when using BioPro products versus
not? If so, you'd be the first person I think I've heard from who
does...

Marc

Reply | Threaded
Open this post in threaded view
|

Re: psychologists and psychiatric drugs

furnitureguru1
Naah. Can't actually tell but my Doc can. It's all cumulative so actuallyfeeling better happens over time.

Paul


----- Original Message -----
From: Marc Martin
To: [hidden email]
Sent: Thursday, May 24, 2007 1:38 PM
Subject: Re: [eSens] psychologists and psychiatric drugs


> I also use Bio Pro products on all of my phones and have been retested
> (muscle testing) on my phones and environment and am finally getting more
> resistant to EMF!!!

Can you actually tell the difference when using BioPro products versus
not? If so, you'd be the first person I think I've heard from who
does...

Marc


   

[Non-text portions of this message have been removed]

Reply | Threaded
Open this post in threaded view
|

Re: psychologists and psychiatric drugs

Marc Martin
Administrator
> Naah. Can't actually tell but my Doc can. It's all cumulative so
> actually feeling better happens over time.

Actually, some of the devices I've tried work immediately, and
you can immediately tell the difference. Those are my favorite
types of devices....

Marc

Reply | Threaded
Open this post in threaded view
|

Re: psychologists and psychiatric drugs

Andrew McAfee
In reply to this post by Marc Martin
I have some growths on my head as well as some symptoms of a "stealth
virus" as described by Dr. John Martin.
I am hosting him in July with some other speakers to talk about Vaccine
Illnesses.

I find it very interesting just how many diseases are caused by these
types of virus found in vaccines.
Andrew

6 or so articles found here:
http://www.whale.to/vaccines/martin.html

 

NATIONAL VACCINE INFORMATION CENTER

The Human Stealth Virus and Its Animal Origin

THE VACCINE REACTION

"When it happens to you or your child, the risks are 100%"

Vol.1, No.4, Sept./Oct. 1995, Barbara Loe Fisher, Editor

Published bimonthly by the National Vaccine Information Center

 

To The Reader: Since the beginning of September, I have been engaged in
a remarkable dialogue with a scientist at the University of Southern
California whose work I became aware of after reading an article
published in the Riverside Press on August 28. Although the content of
the September October issue of The Vaccine Reaction had already been
scheduled, I came to the conclusion that this story was of such
importance and potentially impacts upon so many individuals suffering
from unexplained neurological, psychiatric and autoimmune disorder
symptoms, that the entire issue should be devoted to covering it. I do
not believe the significance of this research should be underestimated
or minimized and, in the interest of public health and safety, expect
that the Food and Drug Administration and Centers for Disease Control
officials responsible for insuring the public health and safety will
take their responsibilities seriously and act quickly to support
continuation of this research to confirm or disprove these scientific
findings. Failure to act now could jeopardize the health and well being
of every baby born and every child and adult who may already be
infected with an atypical cytopathic virus they contracted through
exposure to contaminated vaccines or exposure to infected blood or body
fluids. - The Editor

DISCOVERY OF AN ATYPICAL VIRUS INFECTING HUMANS LINKED TO VIRAL
VACCINES PRODUCED ON MONKEY TISSUES

 

In what could be one of the most important scientific discoveries of
this decade, an award winning pathologist and immunologist at the
University of Southern California, W. John Martin, M.D., Ph.D., has
discovered an atypical virus infecting both children and adults who are
exhibiting neurological, psychiatric and autoimmune disorder symptoms
with diagnoses including chronic fatigue syndrome, fibromyalgia,
depression, schizophrenia, anxiety disorder, seizures, developmental
delays, autism, lupus, multiple sclerosis, Alzheimer's, Parkinson's,
unexplained encephalopathy and chronic vegetative states. Martin and
his colleagues at USC's Infectious Diseases and Molecular Pathology
Laboratories have been meticulously culturing out stealth viruses from
patients for the past eight years and, in a stunning development
earlier this year, successfully identified one of the viruses as being
of African green monkey origin by using DNA sequence analysis. Kidney
tissues from African green monkeys have been used to make the live oral
polio vaccine (OPV) as well as other viral vaccines during the past
three decades.

YOU CAN BE INFECTED AND NOT BE SICK

 

A distinctive feature of the virus Martin and his colleagues has
characterized is that it belongs to a novel class of atypical
cytopathic viruses (capable of causing pathologic changes in cells),
which they refer to as "stealth viruses" because they have the ability
to evade detection by the body's cellular defense mechanisms and appear
to lack the antigens which normally cause an inflammation typical of
most infections that damage cells and body tissues. The monkey-related
stealth virus they are studying is a cytomegalovirus belonging to the
herpes virus family that causes an atypical viral infection of the
brain - a "stealth virus encephalopathy" - that can produce a spectrum
of disease symptoms without evoking an inflammatory response.

 

Therefore, a person can also become infected and can carry and transmit
the virus to others without exhibiting symptoms. The stealth virus can
remain dormant in an infected but symptomless individual throughout
life. However, in some infected individuals the virus can become
active, triggered perhaps by significant mental or physical stress, and
go on to cause atypical responses to normal sensory input into the
brain resulting in sudden, unexplained neurological symptoms. It is
thought that a stealth virus can be transmitted, like HIV, hepatitis B
or polio, by coming into direct contact with the virus (such as
ingesting or being injected with a contaminated vaccine) or coming into
contact with the blood or body fluids of an infected individual.

CHRONIC FATIGUE SYNDROME, DEPRESSION, ENCEPHALOPATHY

 

In an August 1994 article published in American Journal of Pathologv.
Dr. Martin and his colleagues describe how over a three year period
they repeatedly cultured out an atypical cytopathic virus from a
43-year old woman who became suddenly ill in 1990 with a sore throat,
muscle aches, intense headaches, fever and eventually was hospitalized
with suspected encephalitis/meningitis - although all tests came back
negative. She continued to feel ill and eventually was diagnosed with
chronic fatigue syndrome accompanied by severe headaches, insomnia,
memory loss and brain dysfunction. In that same article, Martin et al
confirm that they also cultured out the same atypical virus from a
patient with severe encephalopathy who had a four year history of manic
depression.

UNSTABLE VIRUS MUTATES EASILY

 

Several months later in an October 1994 article published in the
College of American Pathologists magazine CAP Today, Dr. Martin
explained that "stealth viruses have been derived from herpes viruses
(and possibly other viruses) by a process of major gene deletions and
mutations. These genetic changes presumably account for the lack of an
appreciable inflammatory response and for the wide host range of
infectable cells." Although he acknowledges that neurological,
psychiatric and immune system disorder symptoms can have a variety of
causes, just as stealth viruses present in animals and humans can have
different origins, Martin is pursuing the particular stealth virus he
has identified because he has been able to scientifically prove its
genetic relationship to African green monkey cytomegalovirus.

 

"The animal stealth virus we have identified has an unstable genome and
it mutates easily. It doesn't grow very well in culture and so it can
be easily overlooked during testing. Of concern is the fact that, when
you introduce unstable animal stealth viruses into man, there is a risk
of recombinant (the formation of new combinations of linked genes)
events occurring which can produce new kinds of diseases. Now that we
have the technology, it is very important to act immediately to screen
viral vaccines for stealth viruses, to determine who is already
infected and to develop therapies to interrupt activation as well as
treat those who already have symptoms."

UNEXPLAINED SEIZURES, DEVELOPMENTAL DELAYS, MS, LUPUS, SCHIZOPHRENIA

 

In the CAP Today article, Dr. Martin reports on several cases including
a 19 year old boy who had suffered unexplained severe brain damage at
age 17 and a six month old infant with unexplained seizures and delayed
neurological development. Both patients had tested negative for brain
inflammation but tested positive for stealth virus infection. In
another case Martin describes several more patients who tested positive
for stealth virus infection such as the woman who had been diagnosed by
various doctors as having multiple sclerosis, lupus and cerebral
pseudotumor and a woman who was diagnosed as schizophrenic at age 19,
then manic depressive with delusions. Four years later she experienced
a near-fatal encephalopathy with cardiac arrest and has remained in a
vegetative state for five years.

 

In one family being studied by Martin and his colleagues, four family
members have tested positive for stealth virus infection including a
husband and wife diagnosed with chronic fatigue syndrome, the wife's
mother diagnosed with atypical Parkinson's disease and a son diagnosed
with schizophrenia. All of these patients are now being diagnosed as
suffering from stealth virus encephalopathy.

AUTISTIC CHILD INFECTED WITH STEALTH VIRUS

 

In a letter published in early 1995 in the Journal of Autism and
developmental Disorders, Dr. Martin described the case of a 10 year old
boy who began exhibiting autistic behavior at age one, was diagnosed as
classically autistic at age four and currently exhibits ritualistic and
aggressive behavior that is so difficult to control that he has been
institutionalized. He has repeatedly tested positive for infection with
the stealth virus and Martin concluded, "Repeated culturing a stealth
virus from an autistic patient does not establish that the virus is
responsible for the patient's illness. Symptoms of autism are, however,
consistent with impaired neurosensory functions due to persistent viral
infection and previous attempts to demonstrate viruses in such patients
may have failed to detect stealth viruses."

DNA SEQUENCING OF VIRUS LEADS TO MONKEY ORIGINS

 

In an article published in the July 1995 issue of Clinical and
Diagnostic Virology, Martin and his colleagues describe how they
conducted DNA and amino acid sequence comparisons showing that the
stealth virus isolated from a patient with chronic fatigue syndrome
(CFS) was "more closely related to the Colburn strain of simian
cytomegalovirus than to cytomegalovirus of either human or rhesus
monkey origin or to any other sequenced herpes virus." These
comparisons were confirmed using polymerase chain reaction (PCR). The
scientists concluded that "the findings implicate the African green
monkey as the probable source of the virus isolated from this CFS
patient." They go on to suggest that "the potential introduction of
pathogenic viral variants into humans through the use of African green
monkey-derived cell lines in live virus vaccine production should be
evaluated."

ANlMALS GET SICK TOO

 

Martin and his colleagues have performed more than 1,000 cultures in
their eight-year study of the stealth virus and have found that not
only is there a clustering of culture positive findings in members Of
the same families but that there is also a pattern of unexplained
neurological illnesses in the pet dogs and cats of patients diagnosed
with chronic fatigue syndrome, indicating that the stealth virus may
also be capable of infecting and being carried by animals. Testing this
hypothesis, the scientists have isolated the monkey-related stealth
virus from a culture-positive human patient and injected it into cats.
In an article to be published in the December issue of Pathobiology,
they report their remarkable findings of what happens to the cats after
they have been infected with the Virus.

THE MONEY HAS RUN OUT

 

A casualty of the budget cuts that are hitting California and other
localities across the country, the minimal funding that has helped
USC's Infectious Diseases and Molecular Pathology Lab conduct stealth
virus research has now been exhausted. The Lab has been forced to
drastically cut back on its research linking the proliferation of
atypical neurologic, psychiatric and immune system disorders in
children and adults to the detection of an atypical cytomegalovirus
whose genetic code is almost identical to that of a virus that is
commonly present in the kidney tissues of the African green monkey and
could have, therefore, been inadvertently transmitted to humans during
the production of the oral polio vaccine. Committed to continuing their
research because they know their discovery has the potential to save
lives, Martin and his seven colleagues have continued to work without
pay for the past month in an effort to keep USC's lab open.

AN APPEAL TO THE FDA

 

Dr. Martin, who is professor of pathology and director of USC's
Infectious Diseases and Molecular Pathology Lab, has received numerous
awards, scholarships and fellowships during his 30-year career as a
distinguished scientist at Harvard, University College in London,
University of Sydney in Australia, NIH, Food and Drug Administration,
and the National Cancer Institute. In June, Dr. Martin and S. Zaki
Salahuddin, Ph.D., Li Chang Zeng, M.D., Khalid Ahmed, M.T., Jing G.
Seward, M.D., John-Carl Olsen, Inderjit Singh Seehrai, M.D., and Mark
Nowicki, Ph.D., applied to the FDA for a 6-month grant to:

 

1) Determine the prevalence of simian cytomegalovirus derived stealth
viral infection in humans;

 

They are proposing a simple, quick and cost-effective way to do that by
performing serological, polymerase chain reaction (PCR) and viral
culture testing of blood and lymphocyte samples already stored in the
National Heart, Lung and Blood Institute at NIH which were obtained
during the federally funded Transfusion Safety Study (TSS) conducted in
the 1 980's. The University of Southern California acted as the prime
contractor for the TSS, a study which was conducted because of the fear
that blood products were contaminated with viruses, including HIV. The
goal of the Transfusion Safety Study was to try to determine the
prevalence of viral infections, including HIV, in well defined
populations in the U.S.

 

In addition to the proposal to test the TSS samples for stealth virus
infection, Martin has already obtained permission from the Los Angeles
County - University of Southern California Medical Center's
Institutional Review Board to test blood and fluid samples stored in
their archives if funding can be obtained to do it. The scientists
estimate that if they tested a total of 250 blood samples from both of
these sources, it would be adequate to make an initial scientific
determination of the scope of stealth virus presence in the U.S.
population.

 

2) To screen monkey colonies used for the production of viral vaccines
for the presence of stealth viruses.

 

They are proposing that immediate steps be taken to stop using monkeys
that are infected with the stealth cytomegalovirus to make vaccines by
culturing blood from each monkey designated as a source of kidney
tissue for vaccine production including performing PCR and viral
cultures to test for the presence of stealth virus.

ACT NOW TO SCREEN VACCINES AND BLOOD SUPPLY

 

Martin and his colleagues concluded their appeal to the FDA to give
them a six-month grant to fund their work with these words: FDA is
responsible for the safety of biological products including vaccines
and the Nation's blood supply. As described in the Appendix to this
proposal, stealth viruses have been associated with severe neurological
illnesses. It is imperative that the issue of the potential prior
transfer of pathogenic stealth viruses into humans be addressed. This
proposal will provide much needed data to assess the overall prevalence
of stealth viral infection and the proportion of these infections
attributed to a cytomegalovirus derived stealth virus of African green
monkey origin. The proposal is also an important step towards ensuring
that future vaccine lots are free of stealth viruses. The findings will
also have bearing on the possible need to screen blood donors for the
presence of stealth viruses."

THERAPIES ARE BEING DEVELOPED

 

A major goal of Martin's research is to not only identify individuals
who are infected but to develop antiviral therapies which can interrupt
the activation of a stealth virus in infected but symptomless
individuals as well as help those who are already exhibiting mild to
severe symptoms. Martin maintains that stealth viruses, whether of
animal or human origin, may also play a role yet to be identified in
other illnesses such as arteriosclerosis, autoimmune thyroid disease,
gastrointestinal and kidney disease, infertility and cancer. He and his
colleagues are working on isolating a genetically engineered component
of the stealth virus which an infected individual could take orally to
inhibit its activation and growth.

NVIC WILL OPERATE REGISTRY AND SUPPORT NETWORK

 

In a continuing effort to collect information from parents of children
as well as adults who have been adversely affected by vaccines, the
National Vaccine Information Center will expand the scope of its 1
4-year old vaccine reaction registry and begin collecting information
and providing referrals to those who are suffering from unexplained
neurological, psychiatric and autoimmune disorder symptoms that are
potentially related to stealth virus infection. Parents of children or
adults who are exhibiting symptoms such as those described in this
newsletter and who want to be included in NVIC's registry will be sent
a questionnaire to fill out. To register and obtain a questionnaire,
write to Vaccine Reaction Registry, NVIC, 512 W. Maple Ave., Suite 206,
Vienna, VA 22180. Please include a $5 donation to cover processing and
data entry costs.

 

Once the questionnaire is returned, NVIC can offer assistance to
registrars on how they can follow-up and be tested for stealth virus
infection and, additionally, determine whether they should or would
like to consider becoming part of the stealth virus research laboratory
test database being developed by the USC lab.

 

NVIC is also expanding its 14-year old support network to help stealth
virus positive individuals to communicate with each other to exchange
information as well as become active in the promotion of research to
develop therapies and prevent infection.

Reprinted in Issue No. 87 of the Leading Edge International Research
Journal

Leading Edge Research Group, P.O. Box 7530, Yelm, Washington 98597 USA
- E-Mail: [hidden email]


On May 24, 2007, at 1:25 PM, Marc Martin wrote:

>> I was wondering if anyone would share if they've seen psychologists
>> about
>> their eSens issues and if they were any help, and if anyone has tried
>> antidepressants like lexapro and other drugs and what effect they had
>> on
>> their senstivities.
>
> Early on in my ES (7 years ago), I found that taking antibiotics
> eliminated my ES, but these were causing other problems and
> certainly were not something that I wanted to be taking
> forever. And they were only a temporary solution, as soon
> as I stopped taking them, my ES came back.
>
> The fact that antibiotics helped at all is rather interesting
> though, and leads me to wonder what the mechanism of action was.
> I can only think of two possibilities:
>
> * my ES is caused by some sort of chronic infection.
> * my ES is caused by excessive mobilization of toxins,
> and the antibiotics interferred with this.
>
> But I agree that going to a psychologist is probably useless.
> This is a physical condition, not a mental one.
>
> Marc
>
>
>
> Yahoo! Groups Links
>
>
>
>

Reply | Threaded
Open this post in threaded view
|

Re: psychologists and psychiatric drugs

furnitureguru1
In reply to this post by Marc Martin
What works right away for you?
Paul
----- Original Message -----
From: Marc Martin
To: [hidden email]
Sent: Thursday, May 24, 2007 2:33 PM
Subject: Re: [eSens] psychologists and psychiatric drugs


> Naah. Can't actually tell but my Doc can. It's all cumulative so
> actually feeling better happens over time.

Actually, some of the devices I've tried work immediately, and
you can immediately tell the difference. Those are my favorite
types of devices....

Marc



   

[Non-text portions of this message have been removed]

Reply | Threaded
Open this post in threaded view
|

Re: What works right away for you?

Marc Martin
Administrator
> What works right away for you?

There are several EMF protection devices that I've tried over
the years that I could feel something within minutes. Sometimes
what I feel isn't necessarily good, although in some cases I
slowly adjust to the device over a period of weeks and then get
longterm benefits.

The items which have provided me the most immediate benefits
in harsh EMF environments and have been most used sucessfully
longterm are from Quantum Products:

http://www.natural-stress-reduction.com/stress-relief-products.html

Specifically the Power Conditioner (plug your computer or TV into
it, or just plug it into the wall with nothing attached to it),
the Quantum Byte software (runs on your computer), the Quantum
Home (wide radius of effectiveness -- good for florescent lights),
Quantum Companion (not as strong, but portable).


Another item which provides quick relief, although overuse can
cause side effects for me are Springlife Polarizers. Mostly I use
the OM pendant (put into my pants pocket or near the TV/computer):

http://choosecra.com/htmlpages/homepage/prodinfo/springlife.html


Other notable items are the Earthcalm Resonator, which works
quickly, but I find myself suffering side effects too quickly
from it to be of much practical use (some say that you get
used to it eventually -- I can't even try that, as I've
lost mine somewhere):

http://earthcalm.net/personal.html

Also the RADAR card, which isn't very powerful, but it also
isn't very expensive:

http://www.radar3.com/

Also the Personal Polarizer, which is also cheap:

http://bewisepolarize.com/personal%20polarizer.htm

from my experience, these have proven to be the most useful
things on the EMF protection device market. And I've
tried a lot of stuff, although certainly not *everything*
that is available.

Marc

Reply | Threaded
Open this post in threaded view
|

Re: psychologists and psychiatric drugs

skrzn
In reply to this post by Andrew McAfee
What kind of growths? I get something like small scabs on skin on one part of my head
under hair, don't know what they look like, but can be scratched off and regrow - this is
only in winter. Less over the past few years.
I've always thought that this is some kind of detox, since this happened after I started
the paleolithic diet.

The best (and only AFAIK) stuff to be rid of viruses (and germs) is *pure* oil of wild
oregano - took 2 drops on tongue years ago, I went from a weak cripple oneday to
Superman the next.

William



--- In [hidden email], Andrew McAfee <amcafeerr@...> wrote:

>
> I have some growths on my head as well as some symptoms of a "stealth
> virus" as described by Dr. John Martin.
> I am hosting him in July with some other speakers to talk about Vaccine
> Illnesses.
>
> I find it very interesting just how many diseases are caused by these
> types of virus found in vaccines.
> Andrew
>
> 6 or so articles found here:
> http://www.whale.to/vaccines/martin.html
>
>  
>
> NATIONAL VACCINE INFORMATION CENTER
>
> The Human Stealth Virus and Its Animal Origin
>
> THE VACCINE REACTION
>
> "When it happens to you or your child, the risks are 100%"
>
> Vol.1, No.4, Sept./Oct. 1995, Barbara Loe Fisher, Editor
>
> Published bimonthly by the National Vaccine Information Center
>
>  
>
> To The Reader: Since the beginning of September, I have been engaged in
> a remarkable dialogue with a scientist at the University of Southern
> California whose work I became aware of after reading an article
> published in the Riverside Press on August 28. Although the content of
> the September October issue of The Vaccine Reaction had already been
> scheduled, I came to the conclusion that this story was of such
> importance and potentially impacts upon so many individuals suffering
> from unexplained neurological, psychiatric and autoimmune disorder
> symptoms, that the entire issue should be devoted to covering it. I do
> not believe the significance of this research should be underestimated
> or minimized and, in the interest of public health and safety, expect
> that the Food and Drug Administration and Centers for Disease Control
> officials responsible for insuring the public health and safety will
> take their responsibilities seriously and act quickly to support
> continuation of this research to confirm or disprove these scientific
> findings. Failure to act now could jeopardize the health and well being
> of every baby born and every child and adult who may already be
> infected with an atypical cytopathic virus they contracted through
> exposure to contaminated vaccines or exposure to infected blood or body
> fluids. - The Editor
>
> DISCOVERY OF AN ATYPICAL VIRUS INFECTING HUMANS LINKED TO VIRAL
> VACCINES PRODUCED ON MONKEY TISSUES
>
>  
>
> In what could be one of the most important scientific discoveries of
> this decade, an award winning pathologist and immunologist at the
> University of Southern California, W. John Martin, M.D., Ph.D., has
> discovered an atypical virus infecting both children and adults who are
> exhibiting neurological, psychiatric and autoimmune disorder symptoms
> with diagnoses including chronic fatigue syndrome, fibromyalgia,
> depression, schizophrenia, anxiety disorder, seizures, developmental
> delays, autism, lupus, multiple sclerosis, Alzheimer's, Parkinson's,
> unexplained encephalopathy and chronic vegetative states. Martin and
> his colleagues at USC's Infectious Diseases and Molecular Pathology
> Laboratories have been meticulously culturing out stealth viruses from
> patients for the past eight years and, in a stunning development
> earlier this year, successfully identified one of the viruses as being
> of African green monkey origin by using DNA sequence analysis. Kidney
> tissues from African green monkeys have been used to make the live oral
> polio vaccine (OPV) as well as other viral vaccines during the past
> three decades.
>
> YOU CAN BE INFECTED AND NOT BE SICK
>
>  
>
> A distinctive feature of the virus Martin and his colleagues has
> characterized is that it belongs to a novel class of atypical
> cytopathic viruses (capable of causing pathologic changes in cells),
> which they refer to as "stealth viruses" because they have the ability
> to evade detection by the body's cellular defense mechanisms and appear
> to lack the antigens which normally cause an inflammation typical of
> most infections that damage cells and body tissues. The monkey-related
> stealth virus they are studying is a cytomegalovirus belonging to the
> herpes virus family that causes an atypical viral infection of the
> brain - a "stealth virus encephalopathy" - that can produce a spectrum
> of disease symptoms without evoking an inflammatory response.
>
>  
>
> Therefore, a person can also become infected and can carry and transmit
> the virus to others without exhibiting symptoms. The stealth virus can
> remain dormant in an infected but symptomless individual throughout
> life. However, in some infected individuals the virus can become
> active, triggered perhaps by significant mental or physical stress, and
> go on to cause atypical responses to normal sensory input into the
> brain resulting in sudden, unexplained neurological symptoms. It is
> thought that a stealth virus can be transmitted, like HIV, hepatitis B
> or polio, by coming into direct contact with the virus (such as
> ingesting or being injected with a contaminated vaccine) or coming into
> contact with the blood or body fluids of an infected individual.
>
> CHRONIC FATIGUE SYNDROME, DEPRESSION, ENCEPHALOPATHY
>
>  
>
> In an August 1994 article published in American Journal of Pathologv.
> Dr. Martin and his colleagues describe how over a three year period
> they repeatedly cultured out an atypical cytopathic virus from a
> 43-year old woman who became suddenly ill in 1990 with a sore throat,
> muscle aches, intense headaches, fever and eventually was hospitalized
> with suspected encephalitis/meningitis - although all tests came back
> negative. She continued to feel ill and eventually was diagnosed with
> chronic fatigue syndrome accompanied by severe headaches, insomnia,
> memory loss and brain dysfunction. In that same article, Martin et al
> confirm that they also cultured out the same atypical virus from a
> patient with severe encephalopathy who had a four year history of manic
> depression.
>
> UNSTABLE VIRUS MUTATES EASILY
>
>  
>
> Several months later in an October 1994 article published in the
> College of American Pathologists magazine CAP Today, Dr. Martin
> explained that "stealth viruses have been derived from herpes viruses
> (and possibly other viruses) by a process of major gene deletions and
> mutations. These genetic changes presumably account for the lack of an
> appreciable inflammatory response and for the wide host range of
> infectable cells." Although he acknowledges that neurological,
> psychiatric and immune system disorder symptoms can have a variety of
> causes, just as stealth viruses present in animals and humans can have
> different origins, Martin is pursuing the particular stealth virus he
> has identified because he has been able to scientifically prove its
> genetic relationship to African green monkey cytomegalovirus.
>
>  
>
> "The animal stealth virus we have identified has an unstable genome and
> it mutates easily. It doesn't grow very well in culture and so it can
> be easily overlooked during testing. Of concern is the fact that, when
> you introduce unstable animal stealth viruses into man, there is a risk
> of recombinant (the formation of new combinations of linked genes)
> events occurring which can produce new kinds of diseases. Now that we
> have the technology, it is very important to act immediately to screen
> viral vaccines for stealth viruses, to determine who is already
> infected and to develop therapies to interrupt activation as well as
> treat those who already have symptoms."
>
> UNEXPLAINED SEIZURES, DEVELOPMENTAL DELAYS, MS, LUPUS,
SCHIZOPHRENIA

>
>  
>
> In the CAP Today article, Dr. Martin reports on several cases including
> a 19 year old boy who had suffered unexplained severe brain damage at
> age 17 and a six month old infant with unexplained seizures and delayed
> neurological development. Both patients had tested negative for brain
> inflammation but tested positive for stealth virus infection. In
> another case Martin describes several more patients who tested positive
> for stealth virus infection such as the woman who had been diagnosed by
> various doctors as having multiple sclerosis, lupus and cerebral
> pseudotumor and a woman who was diagnosed as schizophrenic at age 19,
> then manic depressive with delusions. Four years later she experienced
> a near-fatal encephalopathy with cardiac arrest and has remained in a
> vegetative state for five years.
>
>  
>
> In one family being studied by Martin and his colleagues, four family
> members have tested positive for stealth virus infection including a
> husband and wife diagnosed with chronic fatigue syndrome, the wife's
> mother diagnosed with atypical Parkinson's disease and a son diagnosed
> with schizophrenia. All of these patients are now being diagnosed as
> suffering from stealth virus encephalopathy.
>
> AUTISTIC CHILD INFECTED WITH STEALTH VIRUS
>
>  
>
> In a letter published in early 1995 in the Journal of Autism and
> developmental Disorders, Dr. Martin described the case of a 10 year old
> boy who began exhibiting autistic behavior at age one, was diagnosed as
> classically autistic at age four and currently exhibits ritualistic and
> aggressive behavior that is so difficult to control that he has been
> institutionalized. He has repeatedly tested positive for infection with
> the stealth virus and Martin concluded, "Repeated culturing a stealth
> virus from an autistic patient does not establish that the virus is
> responsible for the patient's illness. Symptoms of autism are, however,
> consistent with impaired neurosensory functions due to persistent viral
> infection and previous attempts to demonstrate viruses in such patients
> may have failed to detect stealth viruses."
>
> DNA SEQUENCING OF VIRUS LEADS TO MONKEY ORIGINS
>
>  
>
> In an article published in the July 1995 issue of Clinical and
> Diagnostic Virology, Martin and his colleagues describe how they
> conducted DNA and amino acid sequence comparisons showing that the
> stealth virus isolated from a patient with chronic fatigue syndrome
> (CFS) was "more closely related to the Colburn strain of simian
> cytomegalovirus than to cytomegalovirus of either human or rhesus
> monkey origin or to any other sequenced herpes virus." These
> comparisons were confirmed using polymerase chain reaction (PCR). The
> scientists concluded that "the findings implicate the African green
> monkey as the probable source of the virus isolated from this CFS
> patient." They go on to suggest that "the potential introduction of
> pathogenic viral variants into humans through the use of African green
> monkey-derived cell lines in live virus vaccine production should be
> evaluated."
>
> ANlMALS GET SICK TOO
>
>  
>
> Martin and his colleagues have performed more than 1,000 cultures in
> their eight-year study of the stealth virus and have found that not
> only is there a clustering of culture positive findings in members Of
> the same families but that there is also a pattern of unexplained
> neurological illnesses in the pet dogs and cats of patients diagnosed
> with chronic fatigue syndrome, indicating that the stealth virus may
> also be capable of infecting and being carried by animals. Testing this
> hypothesis, the scientists have isolated the monkey-related stealth
> virus from a culture-positive human patient and injected it into cats.
> In an article to be published in the December issue of Pathobiology,
> they report their remarkable findings of what happens to the cats after
> they have been infected with the Virus.
>
> THE MONEY HAS RUN OUT
>
>  
>
> A casualty of the budget cuts that are hitting California and other
> localities across the country, the minimal funding that has helped
> USC's Infectious Diseases and Molecular Pathology Lab conduct stealth
> virus research has now been exhausted. The Lab has been forced to
> drastically cut back on its research linking the proliferation of
> atypical neurologic, psychiatric and immune system disorders in
> children and adults to the detection of an atypical cytomegalovirus
> whose genetic code is almost identical to that of a virus that is
> commonly present in the kidney tissues of the African green monkey and
> could have, therefore, been inadvertently transmitted to humans during
> the production of the oral polio vaccine. Committed to continuing their
> research because they know their discovery has the potential to save
> lives, Martin and his seven colleagues have continued to work without
> pay for the past month in an effort to keep USC's lab open.
>
> AN APPEAL TO THE FDA
>
>  
>
> Dr. Martin, who is professor of pathology and director of USC's
> Infectious Diseases and Molecular Pathology Lab, has received numerous
> awards, scholarships and fellowships during his 30-year career as a
> distinguished scientist at Harvard, University College in London,
> University of Sydney in Australia, NIH, Food and Drug Administration,
> and the National Cancer Institute. In June, Dr. Martin and S. Zaki
> Salahuddin, Ph.D., Li Chang Zeng, M.D., Khalid Ahmed, M.T., Jing G.
> Seward, M.D., John-Carl Olsen, Inderjit Singh Seehrai, M.D., and Mark
> Nowicki, Ph.D., applied to the FDA for a 6-month grant to:
>
>  
>
> 1) Determine the prevalence of simian cytomegalovirus derived stealth
> viral infection in humans;
>
>  
>
> They are proposing a simple, quick and cost-effective way to do that by
> performing serological, polymerase chain reaction (PCR) and viral
> culture testing of blood and lymphocyte samples already stored in the
> National Heart, Lung and Blood Institute at NIH which were obtained
> during the federally funded Transfusion Safety Study (TSS) conducted in
> the 1 980's. The University of Southern California acted as the prime
> contractor for the TSS, a study which was conducted because of the fear
> that blood products were contaminated with viruses, including HIV. The
> goal of the Transfusion Safety Study was to try to determine the
> prevalence of viral infections, including HIV, in well defined
> populations in the U.S.
>
>  
>
> In addition to the proposal to test the TSS samples for stealth virus
> infection, Martin has already obtained permission from the Los Angeles
> County - University of Southern California Medical Center's
> Institutional Review Board to test blood and fluid samples stored in
> their archives if funding can be obtained to do it. The scientists
> estimate that if they tested a total of 250 blood samples from both of
> these sources, it would be adequate to make an initial scientific
> determination of the scope of stealth virus presence in the U.S.
> population.
>
>  
>
> 2) To screen monkey colonies used for the production of viral vaccines
> for the presence of stealth viruses.
>
>  
>
> They are proposing that immediate steps be taken to stop using monkeys
> that are infected with the stealth cytomegalovirus to make vaccines by
> culturing blood from each monkey designated as a source of kidney
> tissue for vaccine production including performing PCR and viral
> cultures to test for the presence of stealth virus.
>
> ACT NOW TO SCREEN VACCINES AND BLOOD SUPPLY
>
>  
>
> Martin and his colleagues concluded their appeal to the FDA to give
> them a six-month grant to fund their work with these words: FDA is
> responsible for the safety of biological products including vaccines
> and the Nation's blood supply. As described in the Appendix to this
> proposal, stealth viruses have been associated with severe neurological
> illnesses. It is imperative that the issue of the potential prior
> transfer of pathogenic stealth viruses into humans be addressed. This
> proposal will provide much needed data to assess the overall prevalence
> of stealth viral infection and the proportion of these infections
> attributed to a cytomegalovirus derived stealth virus of African green
> monkey origin. The proposal is also an important step towards ensuring
> that future vaccine lots are free of stealth viruses. The findings will
> also have bearing on the possible need to screen blood donors for the
> presence of stealth viruses."
>
> THERAPIES ARE BEING DEVELOPED
>
>  
>
> A major goal of Martin's research is to not only identify individuals
> who are infected but to develop antiviral therapies which can interrupt
> the activation of a stealth virus in infected but symptomless
> individuals as well as help those who are already exhibiting mild to
> severe symptoms. Martin maintains that stealth viruses, whether of
> animal or human origin, may also play a role yet to be identified in
> other illnesses such as arteriosclerosis, autoimmune thyroid disease,
> gastrointestinal and kidney disease, infertility and cancer. He and his
> colleagues are working on isolating a genetically engineered component
> of the stealth virus which an infected individual could take orally to
> inhibit its activation and growth.
>
> NVIC WILL OPERATE REGISTRY AND SUPPORT NETWORK
>
>  
>
> In a continuing effort to collect information from parents of children
> as well as adults who have been adversely affected by vaccines, the
> National Vaccine Information Center will expand the scope of its 1
> 4-year old vaccine reaction registry and begin collecting information
> and providing referrals to those who are suffering from unexplained
> neurological, psychiatric and autoimmune disorder symptoms that are
> potentially related to stealth virus infection. Parents of children or
> adults who are exhibiting symptoms such as those described in this
> newsletter and who want to be included in NVIC's registry will be sent
> a questionnaire to fill out. To register and obtain a questionnaire,
> write to Vaccine Reaction Registry, NVIC, 512 W. Maple Ave., Suite 206,
> Vienna, VA 22180. Please include a $5 donation to cover processing and
> data entry costs.
>
>  
>
> Once the questionnaire is returned, NVIC can offer assistance to
> registrars on how they can follow-up and be tested for stealth virus
> infection and, additionally, determine whether they should or would
> like to consider becoming part of the stealth virus research laboratory
> test database being developed by the USC lab.
>
>  
>
> NVIC is also expanding its 14-year old support network to help stealth
> virus positive individuals to communicate with each other to exchange
> information as well as become active in the promotion of research to
> develop therapies and prevent infection.
>
> Reprinted in Issue No. 87 of the Leading Edge International Research
> Journal
>
> Leading Edge Research Group, P.O. Box 7530, Yelm, Washington 98597 USA
> - E-Mail: trufax@...
>
>
> On May 24, 2007, at 1:25 PM, Marc Martin wrote:
>
> >> I was wondering if anyone would share if they've seen psychologists
> >> about
> >> their eSens issues and if they were any help, and if anyone has tried
> >> antidepressants like lexapro and other drugs and what effect they had
> >> on
> >> their senstivities.
> >
> > Early on in my ES (7 years ago), I found that taking antibiotics
> > eliminated my ES, but these were causing other problems and
> > certainly were not something that I wanted to be taking
> > forever. And they were only a temporary solution, as soon
> > as I stopped taking them, my ES came back.
> >
> > The fact that antibiotics helped at all is rather interesting
> > though, and leads me to wonder what the mechanism of action was.
> > I can only think of two possibilities:
> >
> > * my ES is caused by some sort of chronic infection.
> > * my ES is caused by excessive mobilization of toxins,
> > and the antibiotics interferred with this.
> >
> > But I agree that going to a psychologist is probably useless.
> > This is a physical condition, not a mental one.
> >
> > Marc
> >
> >
> >
> > Yahoo! Groups Links
> >
> >
> >
> >
>

Reply | Threaded
Open this post in threaded view
|

Re: psychologists and psychiatric drugs

Andrew McAfee
A doctor called them benign fatty Lypomas and also cysts. Because they
are growing where I also have pain associated with EMF, I think there
is a relationship.
We'll see.
I too like Oregano and Olive Leaf extracts and oils.
andrew
On May 25, 2007, at 8:41 AM, skrzn wrote:

> What kind of growths? I get something like small scabs on skin on one
> part of my head
> under hair, don't know what they look like, but can be scratched off
> and regrow - this is
> only in winter. Less over the past few years.
> I've always thought that this is some kind of detox, since this
> happened after I started
> the paleolithic diet.
>
> The best (and only AFAIK) stuff to be rid of viruses (and germs) is
> *pure* oil of wild
> oregano - took 2 drops on tongue years ago, I went from a weak
> cripple one day to
> Superman the next.
>
> William
>
>
>
> --- In [hidden email], Andrew McAfee <amcafeerr@...> wrote:
>>
>> I have some growths on my head as well as some symptoms of a "stealth
>> virus" as described by Dr. John Martin.
>> I am hosting him in July with some other speakers to talk about
>> Vaccine
>> Illnesses.
>>
>> I find it very interesting just how many diseases are caused by these
>> types of virus found in vaccines.
>> Andrew
>>
>> 6 or so articles found here:
>> http://www.whale.to/vaccines/martin.html
>>
>>  
>>
>> NATIONAL VACCINE INFORMATION CENTER
>>
>> The Human Stealth Virus and Its Animal Origin
>>
>> THE VACCINE REACTION
>>
>> "When it happens to you or your child, the risks are 100%"
>>
>> Vol.1, No.4, Sept./Oct. 1995, Barbara Loe Fisher, Editor
>>
>> Published bimonthly by the National Vaccine Information Center
>>
>>  
>>
>> To The Reader: Since the beginning of September, I have been engaged
>> in
>> a remarkable dialogue with a scientist at the University of Southern
>> California whose work I became aware of after reading an article
>> published in the Riverside Press on August 28. Although the content of
>> the September October issue of The Vaccine Reaction had already been
>> scheduled, I came to the conclusion that this story was of such
>> importance and potentially impacts upon so many individuals suffering
>> from unexplained neurological, psychiatric and autoimmune disorder
>> symptoms, that the entire issue should be devoted to covering it. I do
>> not believe the significance of this research should be underestimated
>> or minimized and, in the interest of public health and safety, expect
>> that the Food and Drug Administration and Centers for Disease Control
>> officials responsible for insuring the public health and safety will
>> take their responsibilities seriously and act quickly to support
>> continuation of this research to confirm or disprove these scientific
>> findings. Failure to act now could jeopardize the health and well
>> being
>> of every baby born and every child and adult who may already be
>> infected with an atypical cytopathic virus they contracted through
>> exposure to contaminated vaccines or exposure to infected blood or
>> body
>> fluids. - The Editor
>>
>> DISCOVERY OF AN ATYPICAL VIRUS INFECTING HUMANS LINKED TO VIRAL
>> VACCINES PRODUCED ON MONKEY TISSUES
>>
>>  
>>
>> In what could be one of the most important scientific discoveries of
>> this decade, an award winning pathologist and immunologist at the
>> University of Southern California, W. John Martin, M.D., Ph.D., has
>> discovered an atypical virus infecting both children and adults who
>> are
>> exhibiting neurological, psychiatric and autoimmune disorder symptoms
>> with diagnoses including chronic fatigue syndrome, fibromyalgia,
>> depression, schizophrenia, anxiety disorder, seizures, developmental
>> delays, autism, lupus, multiple sclerosis, Alzheimer's, Parkinson's,
>> unexplained encephalopathy and chronic vegetative states. Martin and
>> his colleagues at USC's Infectious Diseases and Molecular Pathology
>> Laboratories have been meticulously culturing out stealth viruses from
>> patients for the past eight years and, in a stunning development
>> earlier this year, successfully identified one of the viruses as being
>> of African green monkey origin by using DNA sequence analysis. Kidney
>> tissues from African green monkeys have been used to make the live
>> oral
>> polio vaccine (OPV) as well as other viral vaccines during the past
>> three decades.
>>
>> YOU CAN BE INFECTED AND NOT BE SICK
>>
>>  
>>
>> A distinctive feature of the virus Martin and his colleagues has
>> characterized is that it belongs to a novel class of atypical
>> cytopathic viruses (capable of causing pathologic changes in cells),
>> which they refer to as "stealth viruses" because they have the ability
>> to evade detection by the body's cellular defense mechanisms and
>> appear
>> to lack the antigens which normally cause an inflammation typical of
>> most infections that damage cells and body tissues. The monkey-related
>> stealth virus they are studying is a cytomegalovirus belonging to the
>> herpes virus family that causes an atypical viral infection of the
>> brain - a "stealth virus encephalopathy" - that can produce a spectrum
>> of disease symptoms without evoking an inflammatory response.
>>
>>  
>>
>> Therefore, a person can also become infected and can carry and
>> transmit
>> the virus to others without exhibiting symptoms. The stealth virus can
>> remain dormant in an infected but symptomless individual throughout
>> life. However, in some infected individuals the virus can become
>> active, triggered perhaps by significant mental or physical stress,
>> and
>> go on to cause atypical responses to normal sensory input into the
>> brain resulting in sudden, unexplained neurological symptoms. It is
>> thought that a stealth virus can be transmitted, like HIV, hepatitis B
>> or polio, by coming into direct contact with the virus (such as
>> ingesting or being injected with a contaminated vaccine) or coming
>> into
>> contact with the blood or body fluids of an infected individual.
>>
>> CHRONIC FATIGUE SYNDROME, DEPRESSION, ENCEPHALOPATHY
>>
>>  
>>
>> In an August 1994 article published in American Journal of Pathologv.
>> Dr. Martin and his colleagues describe how over a three year period
>> they repeatedly cultured out an atypical cytopathic virus from a
>> 43-year old woman who became suddenly ill in 1990 with a sore throat,
>> muscle aches, intense headaches, fever and eventually was hospitalized
>> with suspected encephalitis/meningitis - although all tests came back
>> negative. She continued to feel ill and eventually was diagnosed with
>> chronic fatigue syndrome accompanied by severe headaches, insomnia,
>> memory loss and brain dysfunction. In that same article, Martin et al
>> confirm that they also cultured out the same atypical virus from a
>> patient with severe encephalopathy who had a four year history of
>> manic
>> depression.
>>
>> UNSTABLE VIRUS MUTATES EASILY
>>
>>  
>>
>> Several months later in an October 1994 article published in the
>> College of American Pathologists magazine CAP Today, Dr. Martin
>> explained that "stealth viruses have been derived from herpes viruses
>> (and possibly other viruses) by a process of major gene deletions and
>> mutations. These genetic changes presumably account for the lack of an
>> appreciable inflammatory response and for the wide host range of
>> infectable cells." Although he acknowledges that neurological,
>> psychiatric and immune system disorder symptoms can have a variety of
>> causes, just as stealth viruses present in animals and humans can have
>> different origins, Martin is pursuing the particular stealth virus he
>> has identified because he has been able to scientifically prove its
>> genetic relationship to African green monkey cytomegalovirus.
>>
>>  
>>
>> "The animal stealth virus we have identified has an unstable genome
>> and
>> it mutates easily. It doesn't grow very well in culture and so it can
>> be easily overlooked during testing. Of concern is the fact that, when
>> you introduce unstable animal stealth viruses into man, there is a
>> risk
>> of recombinant (the formation of new combinations of linked genes)
>> events occurring which can produce new kinds of diseases. Now that we
>> have the technology, it is very important to act immediately to screen
>> viral vaccines for stealth viruses, to determine who is already
>> infected and to develop therapies to interrupt activation as well as
>> treat those who already have symptoms."
>>
>> UNEXPLAINED SEIZURES, DEVELOPMENTAL DELAYS, MS, LUPUS,
> SCHIZOPHRENIA
>>
>>  
>>
>> In the CAP Today article, Dr. Martin reports on several cases
>> including
>> a 19 year old boy who had suffered unexplained severe brain damage at
>> age 17 and a six month old infant with unexplained seizures and
>> delayed
>> neurological development. Both patients had tested negative for brain
>> inflammation but tested positive for stealth virus infection. In
>> another case Martin describes several more patients who tested
>> positive
>> for stealth virus infection such as the woman who had been diagnosed
>> by
>> various doctors as having multiple sclerosis, lupus and cerebral
>> pseudotumor and a woman who was diagnosed as schizophrenic at age 19,
>> then manic depressive with delusions. Four years later she experienced
>> a near-fatal encephalopathy with cardiac arrest and has remained in a
>> vegetative state for five years.
>>
>>  
>>
>> In one family being studied by Martin and his colleagues, four family
>> members have tested positive for stealth virus infection including a
>> husband and wife diagnosed with chronic fatigue syndrome, the wife's
>> mother diagnosed with atypical Parkinson's disease and a son diagnosed
>> with schizophrenia. All of these patients are now being diagnosed as
>> suffering from stealth virus encephalopathy.
>>
>> AUTISTIC CHILD INFECTED WITH STEALTH VIRUS
>>
>>  
>>
>> In a letter published in early 1995 in the Journal of Autism and
>> developmental Disorders, Dr. Martin described the case of a 10 year
>> old
>> boy who began exhibiting autistic behavior at age one, was diagnosed
>> as
>> classically autistic at age four and currently exhibits ritualistic
>> and
>> aggressive behavior that is so difficult to control that he has been
>> institutionalized. He has repeatedly tested positive for infection
>> with
>> the stealth virus and Martin concluded, "Repeated culturing a stealth
>> virus from an autistic patient does not establish that the virus is
>> responsible for the patient's illness. Symptoms of autism are,
>> however,
>> consistent with impaired neurosensory functions due to persistent
>> viral
>> infection and previous attempts to demonstrate viruses in such
>> patients
>> may have failed to detect stealth viruses."
>>
>> DNA SEQUENCING OF VIRUS LEADS TO MONKEY ORIGINS
>>
>>  
>>
>> In an article published in the July 1995 issue of Clinical and
>> Diagnostic Virology, Martin and his colleagues describe how they
>> conducted DNA and amino acid sequence comparisons showing that the
>> stealth virus isolated from a patient with chronic fatigue syndrome
>> (CFS) was "more closely related to the Colburn strain of simian
>> cytomegalovirus than to cytomegalovirus of either human or rhesus
>> monkey origin or to any other sequenced herpes virus." These
>> comparisons were confirmed using polymerase chain reaction (PCR). The
>> scientists concluded that "the findings implicate the African green
>> monkey as the probable source of the virus isolated from this CFS
>> patient." They go on to suggest that "the potential introduction of
>> pathogenic viral variants into humans through the use of African green
>> monkey-derived cell lines in live virus vaccine production should be
>> evaluated."
>>
>> ANlMALS GET SICK TOO
>>
>>  
>>
>> Martin and his colleagues have performed more than 1,000 cultures in
>> their eight-year study of the stealth virus and have found that not
>> only is there a clustering of culture positive findings in members Of
>> the same families but that there is also a pattern of unexplained
>> neurological illnesses in the pet dogs and cats of patients diagnosed
>> with chronic fatigue syndrome, indicating that the stealth virus may
>> also be capable of infecting and being carried by animals. Testing
>> this
>> hypothesis, the scientists have isolated the monkey-related stealth
>> virus from a culture-positive human patient and injected it into cats.
>> In an article to be published in the December issue of Pathobiology,
>> they report their remarkable findings of what happens to the cats
>> after
>> they have been infected with the Virus.
>>
>> THE MONEY HAS RUN OUT
>>
>>  
>>
>> A casualty of the budget cuts that are hitting California and other
>> localities across the country, the minimal funding that has helped
>> USC's Infectious Diseases and Molecular Pathology Lab conduct stealth
>> virus research has now been exhausted. The Lab has been forced to
>> drastically cut back on its research linking the proliferation of
>> atypical neurologic, psychiatric and immune system disorders in
>> children and adults to the detection of an atypical cytomegalovirus
>> whose genetic code is almost identical to that of a virus that is
>> commonly present in the kidney tissues of the African green monkey and
>> could have, therefore, been inadvertently transmitted to humans during
>> the production of the oral polio vaccine. Committed to continuing
>> their
>> research because they know their discovery has the potential to save
>> lives, Martin and his seven colleagues have continued to work without
>> pay for the past month in an effort to keep USC's lab open.
>>
>> AN APPEAL TO THE FDA
>>
>>  
>>
>> Dr. Martin, who is professor of pathology and director of USC's
>> Infectious Diseases and Molecular Pathology Lab, has received numerous
>> awards, scholarships and fellowships during his 30-year career as a
>> distinguished scientist at Harvard, University College in London,
>> University of Sydney in Australia, NIH, Food and Drug Administration,
>> and the National Cancer Institute. In June, Dr. Martin and S. Zaki
>> Salahuddin, Ph.D., Li Chang Zeng, M.D., Khalid Ahmed, M.T., Jing G.
>> Seward, M.D., John-Carl Olsen, Inderjit Singh Seehrai, M.D., and Mark
>> Nowicki, Ph.D., applied to the FDA for a 6-month grant to:
>>
>>  
>>
>> 1) Determine the prevalence of simian cytomegalovirus derived stealth
>> viral infection in humans;
>>
>>  
>>
>> They are proposing a simple, quick and cost-effective way to do that
>> by
>> performing serological, polymerase chain reaction (PCR) and viral
>> culture testing of blood and lymphocyte samples already stored in the
>> National Heart, Lung and Blood Institute at NIH which were obtained
>> during the federally funded Transfusion Safety Study (TSS) conducted
>> in
>> the 1 980's. The University of Southern California acted as the prime
>> contractor for the TSS, a study which was conducted because of the
>> fear
>> that blood products were contaminated with viruses, including HIV. The
>> goal of the Transfusion Safety Study was to try to determine the
>> prevalence of viral infections, including HIV, in well defined
>> populations in the U.S.
>>
>>  
>>
>> In addition to the proposal to test the TSS samples for stealth virus
>> infection, Martin has already obtained permission from the Los Angeles
>> County - University of Southern California Medical Center's
>> Institutional Review Board to test blood and fluid samples stored in
>> their archives if funding can be obtained to do it. The scientists
>> estimate that if they tested a total of 250 blood samples from both of
>> these sources, it would be adequate to make an initial scientific
>> determination of the scope of stealth virus presence in the U.S.
>> population.
>>
>>  
>>
>> 2) To screen monkey colonies used for the production of viral vaccines
>> for the presence of stealth viruses.
>>
>>  
>>
>> They are proposing that immediate steps be taken to stop using monkeys
>> that are infected with the stealth cytomegalovirus to make vaccines by
>> culturing blood from each monkey designated as a source of kidney
>> tissue for vaccine production including performing PCR and viral
>> cultures to test for the presence of stealth virus.
>>
>> ACT NOW TO SCREEN VACCINES AND BLOOD SUPPLY
>>
>>  
>>
>> Martin and his colleagues concluded their appeal to the FDA to give
>> them a six-month grant to fund their work with these words: FDA is
>> responsible for the safety of biological products including vaccines
>> and the Nation's blood supply. As described in the Appendix to this
>> proposal, stealth viruses have been associated with severe
>> neurological
>> illnesses. It is imperative that the issue of the potential prior
>> transfer of pathogenic stealth viruses into humans be addressed. This
>> proposal will provide much needed data to assess the overall
>> prevalence
>> of stealth viral infection and the proportion of these infections
>> attributed to a cytomegalovirus derived stealth virus of African green
>> monkey origin. The proposal is also an important step towards ensuring
>> that future vaccine lots are free of stealth viruses. The findings
>> will
>> also have bearing on the possible need to screen blood donors for the
>> presence of stealth viruses."
>>
>> THERAPIES ARE BEING DEVELOPED
>>
>>  
>>
>> A major goal of Martin's research is to not only identify individuals
>> who are infected but to develop antiviral therapies which can
>> interrupt
>> the activation of a stealth virus in infected but symptomless
>> individuals as well as help those who are already exhibiting mild to
>> severe symptoms. Martin maintains that stealth viruses, whether of
>> animal or human origin, may also play a role yet to be identified in
>> other illnesses such as arteriosclerosis, autoimmune thyroid disease,
>> gastrointestinal and kidney disease, infertility and cancer. He and
>> his
>> colleagues are working on isolating a genetically engineered component
>> of the stealth virus which an infected individual could take orally to
>> inhibit its activation and growth.
>>
>> NVIC WILL OPERATE REGISTRY AND SUPPORT NETWORK
>>
>>  
>>
>> In a continuing effort to collect information from parents of children
>> as well as adults who have been adversely affected by vaccines, the
>> National Vaccine Information Center will expand the scope of its 1
>> 4-year old vaccine reaction registry and begin collecting information
>> and providing referrals to those who are suffering from unexplained
>> neurological, psychiatric and autoimmune disorder symptoms that are
>> potentially related to stealth virus infection. Parents of children or
>> adults who are exhibiting symptoms such as those described in this
>> newsletter and who want to be included in NVIC's registry will be sent
>> a questionnaire to fill out. To register and obtain a questionnaire,
>> write to Vaccine Reaction Registry, NVIC, 512 W. Maple Ave., Suite
>> 206,
>> Vienna, VA 22180. Please include a $5 donation to cover processing and
>> data entry costs.
>>
>>  
>>
>> Once the questionnaire is returned, NVIC can offer assistance to
>> registrars on how they can follow-up and be tested for stealth virus
>> infection and, additionally, determine whether they should or would
>> like to consider becoming part of the stealth virus research
>> laboratory
>> test database being developed by the USC lab.
>>
>>  
>>
>> NVIC is also expanding its 14-year old support network to help stealth
>> virus positive individuals to communicate with each other to exchange
>> information as well as become active in the promotion of research to
>> develop therapies and prevent infection.
>>
>> Reprinted in Issue No. 87 of the Leading Edge International Research
>> Journal
>>
>> Leading Edge Research Group, P.O. Box 7530, Yelm, Washington 98597 USA
>> - E-Mail: trufax@...
>>
>>
>> On May 24, 2007, at 1:25 PM, Marc Martin wrote:
>>
>>>> I was wondering if anyone would share if they've seen psychologists
>>>> about
>>>> their eSens issues and if they were any help, and if anyone has
>>>> tried
>>>> antidepressants like lexapro and other drugs and what effect they
>>>> had
>>>> on
>>>> their senstivities.
>>>
>>> Early on in my ES (7 years ago), I found that taking antibiotics
>>> eliminated my ES, but these were causing other problems and
>>> certainly were not something that I wanted to be taking
>>> forever. And they were only a temporary solution, as soon
>>> as I stopped taking them, my ES came back.
>>>
>>> The fact that antibiotics helped at all is rather interesting
>>> though, and leads me to wonder what the mechanism of action was.
>>> I can only think of two possibilities:
>>>
>>> * my ES is caused by some sort of chronic infection.
>>> * my ES is caused by excessive mobilization of toxins,
>>> and the antibiotics interferred with this.
>>>
>>> But I agree that going to a psychologist is probably useless.
>>> This is a physical condition, not a mental one.
>>>
>>> Marc
>>>
>>>
>>>
>>> Yahoo! Groups Links
>>>
>>>
>>>
>>>
>>
>
>
>
>
>
> Yahoo! Groups Links
>
>
>
>